{"id":7177,"date":"2025-05-01T11:08:47","date_gmt":"2025-05-01T16:08:47","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=6026"},"modified":"2025-07-13T15:09:16","modified_gmt":"2025-07-13T20:09:16","slug":"nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u975e\u81e8\u5e8a\u958b\u767a\u62c5\u5f53\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3001\u30b9\u30d6\u30e9\u30bf\u30fb\u30d0\u30bf\u30d3\u30e4\u30eb\u535a\u58eb\u304c\u3001\u5149\u907a\u4f1d\u5b66\u7684\u8996\u899a\u56de\u5fa9\u306b\u304a\u3051\u308b\u5148\u99c6\u7684\u306a\u696d\u7e3e\u3067\u8868\u5f70\u3055\u308c\u308b\u3002"},"content":{"rendered":"
\n
\n
\n
\n
\n

<\/h1>\n

\u30d0\u30bf\u30d3\u30e4\u30eb\u6c0f\u304cARVO\u8ca1\u56e3\u3088\u308a2025\u5e74\u30ab\u30fc\u30eb\u30fb\u30ab\u30e0\u30e9\u30b9\u7ffb\u8a33\u7814\u7a76\u8cde\u3092\u53d7\u8cde<\/em><\/h3>\n

\u00a0<\/p>\n<\/div>\n

\n
\n

\u30c0\u30e9\u30b9\u30012025\u5e745\u67081\u65e5 \u2014\u00a0\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>, \u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u65b0\u898f\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u958b\u767a\u3068\u5546\u696d\u5316\u3092\u901a\u3058\u3066\u3001\u73fe\u5b9f\u4e16\u754c\u306b\u304a\u3051\u308b\u76f2\u4eba\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u306b\u53d6\u308a\u7d44\u3080\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b \u306f\u672c\u65e5\u3001\u975e\u81e8\u5e8a\u958b\u767a\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u306e\u30b9\u30d6\u30e9\u30bf\u30fb\u30d0\u30bf\u30d3\u30e3\u30eb\u535a\u58eb\u304c ARVO\u8ca1\u56e3\u3088\u308a2025\u5e74\u30ab\u30fc\u30eb\u30fb\u30ab\u30e0\u30e9\u30b9\u7ffb\u8a33\u7814\u7a76\u8cde\u3092\u53d7\u8cde<\/a> \u5149\u907a\u4f1d\u5b66\u7684\u624b\u6cd5\u306b\u3088\u308b\u8996\u899a\u56de\u5fa9\u306b\u304a\u3051\u308b\u5148\u99c6\u7684\u306a\u696d\u7e3e\u306b\u5bfe\u3057\u3066\u3002.<\/p>\n

$12,000\u306e\u8cde\u91d1\u304c\u6388\u4e0e\u3055\u308c\u308b\u3053\u306e\u8cde\u306f\u3001\u30c8\u30e9\u30f3\u30b9\u30ec\u30fc\u30b7\u30e7\u30ca\u30eb\u30ea\u30b5\u30fc\u30c1\u306b\u5f93\u4e8b\u3059\u308b\u82e5\u624b\u7814\u7a76\u8005\u3092\u8868\u5f70\u3059\u308b\u3082\u306e\u3067\u3059\u3002\u30d0\u30bf\u30d3\u30e4\u30eb\u535a\u58eb\u306f\u3001\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u305f\u3081\u306b\u5149\u611f\u53d7\u6027\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u4f7f\u7528\u3059\u308b\u9769\u65b0\u7684\u306a\u907a\u4f1d\u5b50\u6cbb\u7642\u3067\u3042\u308b\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\uff08MCO-010\uff09\u306e\u30c8\u30e9\u30f3\u30b9\u30ec\u30fc\u30b7\u30e7\u30f3\u306b\u5927\u304d\u304f\u8ca2\u732e\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u6cbb\u7642\u6cd5\u306f\u3001\u7814\u7a76\u5ba4\u3067\u306e\u7814\u7a76\u304b\u3089\u81e8\u5e8a\u8a66\u9a13\u3078\u3068\u9806\u8abf\u306b\u9032\u3093\u3067\u3044\u307e\u3059\u3002, \u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u60a3\u8005\u306e\u6cbb\u7642\u306b\u304a\u3044\u3066\u6709\u671b\u306a\u7d50\u679c\u3092\u793a\u3057\u3066\u3044\u308b<\/a> \u305d\u3057\u3066\u305d\u306e\u4ed6\u306e\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u3002\u30d0\u30bf\u30d3\u30e4\u30eb\u535a\u58eb\u306f\u3001 \u773c\u79d1\u5b66\u7814\u7a76\u30fb\u8996\u899a\u5354\u4f1a\uff08ARVO\uff092025<\/a>\u00a0\u5e74\u6b21\u7dcf\u4f1a\u306f\u30015\u67084\u65e5\u304b\u30898\u65e5\u307e\u3067\u30bd\u30eb\u30c8\u30ec\u30a4\u30af\u30b7\u30c6\u30a3\u3067\u958b\u50ac\u3055\u308c\u308b\u3002.<\/p>\n

ARVO\u8ca1\u56e3\u8cde\u6388\u8cde\u5f0f\u306e\u8a73\u7d30\u306f\u4ee5\u4e0b\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n

\u65e5\u4ed8\uff1a2025\u5e745\u67084\u65e5\uff08\u65e5\uff09
\n\u6642\u9593\uff1a\u5348\u524d11\u664245\u5206\uff5e\u5348\u5f8c1\u6642\uff08\u5c71\u5cb3\u90e8\u6a19\u6e96\u6642\uff09
\n\u5834\u6240\uff1a\u30ab\u30eb\u30d3\u30f3\u30fbL\u30fb\u30e9\u30f3\u30d7\u30c8\u30f3\u30fb\u30bd\u30eb\u30c8\u30d1\u30ec\u30b9\u30fb\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc\u3001155EF\u53f7\u5ba4<\/p>\n

\u201c\u300c\u30d0\u30bf\u30d3\u30e4\u30eb\u535a\u58eb\u306f\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306b\u304a\u3044\u3066\u8996\u529b\u56de\u5fa9\u306b\u95a2\u3059\u308b\u753b\u671f\u7684\u306a\u7814\u7a76\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u3092\u4e3b\u5c0e\u3057\u7d9a\u3051\u3066\u3044\u307e\u3059\u300d\u3068\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u5171\u540c\u5275\u8a2d\u8005\u517c\u793e\u9577\u3067\u3042\u308b\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u5f7c\u306f\u3001\u5f53\u793e\u304c\u7d50\u96c6\u3055\u305b\u305f\u512a\u79c0\u306a\u30c1\u30fc\u30e0\u3092\u4ee3\u8868\u3059\u308b\u4eba\u7269\u3067\u3042\u308a\u3001\u73fe\u5728\u6cbb\u7642\u9078\u629e\u80a2\u304c\u9650\u3089\u308c\u3066\u3044\u308b\u4e16\u754c\u4e2d\u306e\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u306b\u6069\u6075\u3092\u3082\u305f\u3089\u3059\u53ef\u80fd\u6027\u306e\u3042\u308b\u6b21\u4e16\u4ee3\u306e\u8996\u529b\u56de\u5fa9\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u300d\u201d<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066
\n<\/strong>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u73fe\u5728\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308bRESTORE\u30d5\u30a7\u30fc\u30ba2b\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u4e8c\u91cd\u76f2\u691c\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u826f\u597d\u306a\u8a66\u9a13\u7d42\u4e86\u7d50\u679c\u3092\u53d7\u3051\u3066\uff08NCT04945772<\/a>\u540c\u793e\u306f2025\u5e74\u306b\u958b\u59cb\u3059\u308b\u8a08\u753b\u3092\u767a\u8868\u3057\u305f\u3002\u00a0RP\u6cbb\u7642\u85acMCO-010\u306eBLA\u7533\u8acb<\/a>. \u540c\u793e\u306f\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3092\u5b8c\u4e86\u3057\u307e\u3057\u305f\uff08NCT05417126<\/a>\uff09\u3092\u958b\u59cb\u3057\u3001\u00a0\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>\u00a02025\u5e74\u306b\u4e0a\u5e02\u4e88\u5b9a\u306eMCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3068\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u306e\u4e21\u65b9\u306b\u3064\u3044\u3066\u3001FDA\u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u306f\u3001\u7db2\u819c\u840e\u7e2e\u75c7\uff08GA\uff09\u5411\u3051\u306eIND\u7533\u8acb\u6e96\u5099\u304c\u6574\u3063\u305f\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054\u578bMCO-020\u3001\u304a\u3088\u3073\u30ec\u30fc\u30d0\u30fc\u5148\u5929\u6027\u9ed2\u5185\u969c\u5411\u3051\u306eAAV\u88fd\u5264\uff08IND\u7533\u8acb\u306b\u5411\u3051\u305f\u81e8\u5e8a\u8a66\u9a13\u4e2d\uff09\u304c\u542b\u307e\u308c\u307e\u3059\u3002.<\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/strong>
\n\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
\n212-600-1902
\nPR@nanostherapeutics.com<\/a><\/p>\n

\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Batabyal receives 2025 Carl Camras Translational Research Award from ARVO Foundation \u00a0 DALLAS,\u00a0May 1, 2025\u00a0\u2014\u00a0Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative diseases, today announced that Dr. Subrata Batabyal, Director of Nonclinical Development, has received 2025 Carl Camras Translational Research Award from the ARVO Foundation for his pioneering work in optogenetic vision restoration. The award, which comes with a $12,000 prize, recognizes early-career investigators engaged in translational research. Dr. Batabyal significantly contributed to the translation of multi-characteristic opsin (MCO-010), an innovative gene therapy that uses light-sensitive proteins to restore vision in patients […]<\/p>\n","protected":false},"author":6,"featured_media":7180,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-7177","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Director of Nonclinical Development, Dr. Subrata Batabyal, Recognized for Pioneering Work in Optogenetic Vision Restoration - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Director of Nonclinical Development, Dr. Subrata Batabyal, Recognized for Pioneering Work in Optogenetic Vision Restoration - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-01T16:08:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-13T20:09:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Director of Nonclinical Development, Dr. Subrata Batabyal, Recognized for Pioneering Work in Optogenetic Vision Restoration\",\"datePublished\":\"2025-05-01T16:08:47+00:00\",\"dateModified\":\"2025-07-13T20:09:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/\"},\"wordCount\":399,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/NSCOPE_LI_SubrataAward_V1_REV.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/\",\"name\":\"Nanoscope Director of Nonclinical Development, Dr. Subrata Batabyal, Recognized for Pioneering Work in Optogenetic Vision Restoration - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/NSCOPE_LI_SubrataAward_V1_REV.jpg\",\"datePublished\":\"2025-05-01T16:08:47+00:00\",\"dateModified\":\"2025-07-13T20:09:16+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/NSCOPE_LI_SubrataAward_V1_REV.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/NSCOPE_LI_SubrataAward_V1_REV.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/05\\\/01\\\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Director of Nonclinical Development, Dr. Subrata Batabyal, Recognized for Pioneering Work in Optogenetic Vision Restoration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u975e\u81e8\u5e8a\u958b\u767a\u62c5\u5f53\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3001\u30b9\u30d6\u30e9\u30bf\u30fb\u30d0\u30bf\u30d3\u30e4\u30eb\u535a\u58eb\u304c\u3001\u5149\u907a\u4f1d\u5b66\u7684\u8996\u899a\u56de\u5fa9\u306b\u304a\u3051\u308b\u5148\u99c6\u7684\u306a\u696d\u7e3e\u3067\u8868\u5f70\u3055\u308c\u308b - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Director of Nonclinical Development, Dr. Subrata Batabyal, Recognized for Pioneering Work in Optogenetic Vision Restoration - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2025-05-01T16:08:47+00:00","article_modified_time":"2025-07-13T20:09:16+00:00","og_image":[{"width":1200,"height":242,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Director of Nonclinical Development, Dr. Subrata Batabyal, Recognized for Pioneering Work in Optogenetic Vision Restoration","datePublished":"2025-05-01T16:08:47+00:00","dateModified":"2025-07-13T20:09:16+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/"},"wordCount":399,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/04\/NSCOPE_LI_SubrataAward_V1_REV.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/","url":"https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u975e\u81e8\u5e8a\u958b\u767a\u62c5\u5f53\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3001\u30b9\u30d6\u30e9\u30bf\u30fb\u30d0\u30bf\u30d3\u30e4\u30eb\u535a\u58eb\u304c\u3001\u5149\u907a\u4f1d\u5b66\u7684\u8996\u899a\u56de\u5fa9\u306b\u304a\u3051\u308b\u5148\u99c6\u7684\u306a\u696d\u7e3e\u3067\u8868\u5f70\u3055\u308c\u308b - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/04\/NSCOPE_LI_SubrataAward_V1_REV.jpg","datePublished":"2025-05-01T16:08:47+00:00","dateModified":"2025-07-13T20:09:16+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/04\/NSCOPE_LI_SubrataAward_V1_REV.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/04\/NSCOPE_LI_SubrataAward_V1_REV.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2025\/05\/01\/nanoscope-director-of-nonclinical-development-dr-subrata-batabyal-recognized-for-pioneering-work-in-optogenetic-vision-restoration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Director of Nonclinical Development, Dr. Subrata Batabyal, Recognized for Pioneering Work in Optogenetic Vision Restoration"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/7177","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=7177"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/7177\/revisions"}],"predecessor-version":[{"id":7211,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/7177\/revisions\/7211"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/7180"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=7177"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=7177"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=7177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}